0001567619-19-005272.txt : 20190222 0001567619-19-005272.hdr.sgml : 20190222 20190222170258 ACCESSION NUMBER: 0001567619-19-005272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190220 FILED AS OF DATE: 20190222 DATE AS OF CHANGE: 20190222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lane Michael CENTRAL INDEX KEY: 0001740689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 19626530 MAIL ADDRESS: STREET 1: C/O IDEXX LABORATORIES, INC. CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2019-02-20 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001740689 Lane Michael C/O IDEXX LABORATORIES, INC. ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Corporate Vice President Common Stock 2019-02-20 4 M 0 3322 4584 A 6468 D Common Stock 2019-02-20 4 S 0 736 211.5801 D 5732 D Common Stock 592 I by spouse Incentive Stock Option (right-to-buy) 45.84 2019-02-20 4 M 0 3322 D 2023-02-13 Common Stock 3322 0 D Represents the weighted average sales price of the shares sold ranging from a low of $211.5801 to a high of $211.5810 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein. Grant of option to buy 1,661 shares of IDEXX Laboratories, Inc. common stock that became exercisable on the fifth anniversary of the date of grant without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Michael J. Lane 2019-02-22